• Disodium Bicinchoninate in Redox Assays

  2026-09-22

  Disodium bicinchoninate is a water-compatible biochemical reagent whose value extends beyond simple protein quantification. This article connects its chemistry and handling requirements with assay-design lessons from a 2025 granulosa-cell inflammation study while clearly separating direct evidence from practical application.

• SB-505124 Hydrochloride and Cancer Cell Mechanics

  2026-09-21

  SB-505124 hydrochloride offers translational researchers a reversible way to interrogate ALK4/5/7-driven TGF-β and activin signaling alongside emerging models of cancer-cell mechanics. This article connects Smad pathway validation, fibrosis biology, formulation control, and AFM-based phenotyping while defining what the compound can—and cannot—establish about the MRTFA-KCNMB1 axis.

• PPP2R2A Loss Sensitizes HGSOC to CHK1 Inhibition

  2026-09-21

  The reference study identifies low PPP2R2A expression, encoding the PP2A B55α regulatory subunit, as a potential biomarker for sensitivity to CHK1 inhibition in high-grade serous ovarian cancer. Its experiments connect PPP2R2A deficiency with increased replication initiation, c-Myc-associated replication stress, and vulnerability that extends to models resistant to PARP inhibition.

• Oleanolic Acid: From iNOS Biology to Liposome Translation

  2026-09-20

  A translational perspective on how Oleanolic acid, inducible nitric oxide synthase induction, cyclooxygenase-2 modulation, and nanoparticle exclusion chromatography can be integrated into more rigorous antiviral and immune pathway research.

• MTT Cell Viability Assay: Workflow & Optimization

  2026-09-19

  MTT converts cellular redox activity into a practical colorimetric endpoint for proliferation, cytotoxicity, and host-cell safety studies. This guide shows how to optimize the assay and use it responsibly alongside antibacterial experiments such as plantaricin A and OP4 research.

• Prestained Protein Marker for SepM Assays

  2026-09-19

  Use this Triple color protein ladder to track broad-range separation, transfer efficiency, and protein-size confidence in SepM mutation workflows. Its EDTA-free formulation also supports Phosbind SDS-PAGE and fluorescent membrane imaging without heating or extra loading-buffer preparation.

• Chloroquine BA1002: Mechanisms and Research Uses

  2026-09-18

  Chloroquine is a 4-aminoquinoline and lysosomotropic compound used in malaria, autophagy, immunity, oncology, and antiviral research. Its cellular activity is experimentally broad, but in-vitro antiviral or anticancer results do not establish clinical efficacy or safe self-treatment.

• CFTRinh-172 in Precision CFTR Functional Assays

  2026-09-17

  CFTRinh-172 provides a rapid, reversible way to separate CFTR channel activity from CFTR trafficking in epithelial models. Its selectivity makes it especially useful for validating SHC-1-driven surface-abundance changes, cystic fibrosis research, and preclinical studies of secretory diarrhea.

• Imipenem Assay Design for Translational Research

  2026-09-17

  Imipenem is a semisynthetic thienamycin antibiotic with a distinctive PBP-targeting profile. This guide shows how to connect antibacterial, pharmacodynamic, immune-cell, and sepsis-model readouts into a more rigorous translational research workflow.

• SARS-CoV-2 N Protein Disrupts GADD34 Immunity

  2026-09-16

  This Molecules study identifies an atypical stress-granule mechanism by which SARS-CoV-2 nucleocapsid protein sequesters GADD34 mRNA in N+/G3BP1+ foci. The resulting loss of GADD34 impairs IRF3 nuclear localization and interferon production, providing a mechanistic explanation for viral suppression of innate immunity.

• CFTRinh-172: From Channel Blockade to Translation

  2026-09-16

  CFTRinh-172 offers a precise way to separate CFTR channel activity from trafficking and upstream signaling. This thought-leadership perspective connects mechanistic epithelial biology with assay design, cystic fibrosis research, and translational models of secretory disease.

• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-09-15

  Liu et al. describe carrier-platin, a platinum-based nanotherapeutic designed to generate a rapid intracellular reactive oxygen species burst rather than relying on conventional DNA damage. The study links this mechanism to unusually fast cancer-cell killing, activity in multidrug-resistant models, and a distinct cell-death phenotype that is neither classical apoptosis nor ferroptosis.

• U-73122 Workflow for PLC Signaling and Invasion

  2026-09-15

  U-73122 enables acute phospholipase C inhibition across calcium-flux, chemotaxis, inflammation, and cancer-invasion workflows. This guide pairs practical dosing and handling recommendations with pathway controls that help distinguish PLC-dependent effects from nonspecific loss of cell function.

• Sodium dicloxacillin monohydrate for MSSA research

  2026-09-14

  Build more informative MSSA experiments by pairing extracellular and intracellular efficacy measurements with controlled pH and concentration windows. This workflow also adapts a selective spectrophotometric strategy for practical formulation checks while clearly separating validated evidence from assay-development recommendations.

• Asymmetric Cu Nanozyme for AMI Immune Homeostasis

  2026-09-14

  This study develops a bromine-doped, asymmetrically coordinated copper single-atom nanozyme that improves reactive oxygen species scavenging through electronic-structure engineering. In an acute myocardial infarction model, the material links redox control with cardiomyocyte protection, macrophage phenotype regulation, regulatory T-cell activity, and reduced fibrotic remodeling.

7981 records 1/533 page Next 12345 下5页 Last page